Cortical disinhibition in Parkinson's disease

dc.contributor.authorAmmann, Claudia
dc.contributor.authorDileone, Michele
dc.contributor.authorPagge, Cristina
dc.contributor.authorCatanzaro, Valentina
dc.contributor.authorMata Marín, David
dc.contributor.authorHernández Fernández, Frida
dc.contributor.authorMonje, Mariana H. G.
dc.contributor.authorSánchez Ferro, Álvaro
dc.contributor.authorFernández Rodríguez, Beatriz
dc.contributor.authorGasca Salas, Carmen
dc.contributor.authorEt al.
dc.date.accessioned2022-05-03T17:06:30Z
dc.date.available2022-05-03T17:06:30Z
dc.date.issued2020
dc.description.abstractIn Parkinson's disease, striatal dopamine depletion produces profound alterations in the neural activity of the cortico-basal ganglia motor loop, leading to dysfunctional motor output and parkinsonism. A key regulator of motor output is the balance between excitation and inhibition in the primary motor cortex, which can be assessed in humans with transcranial magnetic stimulation techniques. Despite decades of research, the functional state of cortical inhibition in Parkinson's disease remains uncertain. Towards resolving this issue, we applied paired-pulse transcranial magnetic stimulation protocols in 166 patients with Parkinson's disease (57 levodopa-naïve, 50 non-dyskinetic, 59 dyskinetic) and 40 healthy controls (age-matched with the levodopa-naïve group). All patients were studied OFF medication. All analyses were performed with fully automatic procedures to avoid confirmation bias, and we systematically considered and excluded several potential confounding factors such as age, gender, resting motor threshold, EMG background activity and amplitude of the motor evoked potential elicited by the single-pulse test stimuli. Our results show that short-interval intracortical inhibition is decreased in Parkinson's disease compared to controls. This reduction of intracortical inhibition was obtained with relatively low-intensity conditioning stimuli (80% of the resting motor threshold) and was not associated with any significant increase in short-interval intracortical facilitation or intracortical facilitation with the same low-intensity conditioning stimuli, supporting the involvement of cortical inhibitory circuits. Short-interval intracortical inhibition was similarly reduced in levodopa-naïve, non-dyskinetic and dyskinetic patients. Importantly, intracortical inhibition was reduced compared to control subjects also on the less affected side (n = 145), even in de novo drug-naïve patients in whom the less affected side was minimally symptomatic (lateralized Unified Parkinson's Disease Rating Scale part III = 0 or 1, n = 23). These results suggest that cortical disinhibition is a very early, possibly prodromal feature of Parkinson's disease.spa
dc.description.filiationUEMspa
dc.description.impact13.501 JCR (2020) Q1, 6/208 Clinical Neurologyspa
dc.description.impact5.142 SJR (2020) Q1, 35/2446 Medicine (miscellaneous)spa
dc.description.impactNo data IDR 2020spa
dc.description.sponsorshipDepartment of Economy, Industry and Competitiveness and Co-financed by the European Union (FEDER) “A way to make Europe” (grant SAF2017-86246-R MINECO/AEI/FEDER, UE), by “The Michael J. Fox Foundation” (grant 9205) and by Comunidad de Madrid (fellowship 2017-T2/BMD-5231).spa
dc.identifier.citationAmmann, C., Dileone, M., Pagge, C., Catanzaro, V., Mata-Marin, D., Hernández-Fernández, F., Monje, M. H. G., Sánchez-Ferro, A., Fernández-Rodríguez, B., Gasca-Salas, C., Manez-Miro, J. U., Martínez-Fernández, R., Vela-Desojo, L., Alonso-Frech, F., Oliviero, A., Obeso, J. A., & Foffani, G. (2020). Cortical disinhibition in Parkinson’s disease. Brain, 143(11), 3408-3421. https://doi.org/10.1093/brain/awaa274spa
dc.identifier.doi10.1093/brain/awaa274
dc.identifier.issn0006-8950
dc.identifier.issn1460-2156
dc.identifier.urihttp://hdl.handle.net/11268/11191
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://doi.org/10.1093/brain/awaa274spa
dc.rights.accessRightsopen accessspa
dc.subject.otherEnfermedad de parkinsonspa
dc.subject.otherNeurofisiologíaspa
dc.subject.unescoEnfermedad del sistema nerviosospa
dc.subject.unescoFisiologíaspa
dc.titleCortical disinhibition in Parkinson's diseasespa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublication073b4eeb-2a18-4e1b-812a-c4a3db71f6ca
relation.isAuthorOfPublication.latestForDiscovery073b4eeb-2a18-4e1b-812a-c4a3db71f6ca

Files